About Careers Investors EN Products & Services Markets News & Events COVID-19 Contact us ... Markets Biologic Drugs Biologic Drugs Novel glass drug containment solutions and drug delivery devices suitable for the new generation of drugs combined with state-of-art analytical services and reliable technologies and manufacturing equipment. Global biologic sales are expected to grow from approximately $325billion in 2020 to $425 billion by 2024 with an estimated compounded annual growth of approximately 7%.* Biotech drugs, especially monoclonal antibodies (mAbs) and recombinant proteins, allowed the pharmaceutical industry to treat critical and chronic diseases such as osteoporosis, rheumatoid arthritis, and hypercholesterolemia, that were listed as incurable in the past. Biologics are very challenging to stabilize and administrate, especially in a syringe or a drug-delivery device due to their complexity, sensitivity, and viscosity. Moreover, they face stringent regulatory assessment than generics, including the need for clinical trials, which significantly increases costs and timelines to market entry of biosimilar. Complex drugs and self-administration require an appropriate primary packaging selection from the beginning of the bio drug development process. SG can support biopharma companies in the container closure system choice leveraging its 70-year expertise in drug containment solutions, up to the integration into drug delivery systems, backed up by solid characterization analysis. Drug containment solutions Responding to protein-based drug challenges with a new generation of drug containment solutions that enable perfect functionality and integration into drug delivery systems, thus boosting reliability and patient safety. SOLUTION SG Syringe Systems DISCOVER MORE SOLUTION SG Vial Systems DISCOVER MORE SOLUTION SG EZ-fill® Platform DISCOVER MORE Contract Manufacturing Services A broad range of manufacturing services and capabilities to produce high-quality devices able to deliver the latest generation of biodrugs, including large-volume dosage and viscous formulations. SOLUTION Contract manufacturing for drug delivery devices DISCOVER MORE Visual Inspection Flexible inspection systems based on proven technologies and innovative solutions integrating the latest digital developments to assess these challenging drugs’ integrity and to minimize false rejects. SOLUTION PWL Series – semiautomatic equipment DISCOVER MORE SOLUTION Vision Robot Unit featuring Artificial Intelligence for small high value batches DISCOVER MORE Assembly lines State-of-the-art technology for precision assembly solutions. We engineer and manufacture customized solutions for the efficient sub-assembly and final assembly of drug delivery devices, including pen injectors, auto-injectors, wearables, inhalers and nasal sprays. SOLUTION Assembly platforms – from lab to large scale production DISCOVER MORE CASE STUDY Injection Pen Assembly Line DISCOVER MORE ON DEMAND 60 MIN ENGLISH Webinar Addressing Challenges in Biologics advanced and integrated solutions from development to production Other markets we serve Previous Respiratory We offer different solutions linked to sublingual and nasal drug administration. Effective, safe, and simple drug delivery guide our R&D in this field. DISCOVER MORE Next Respiratory Diabetes Treatment 1 2 3 4 1/4 Choose a language English (United States) About Our Heritage Our Brands Vision, Mission & Values Facts & Figures Governance Quality Research & Development Regulatory Support Health, Safety & Environment SG Steps Offering Drug containment solutions Drug Delivery Systems Plastic Solutions Glass Converting Visual Inspection Assembly equipment Secondary Packaging Analytical Services News & Event News Events Press Releases Webinars Media Wall Contact Us Global Presence Careers Life at Stevanato Group Job Opportunities Schools & Universities Social: © 2021 Stevanato Group. All Right Reserved - P.IVA 01487430280 Code of Ethics Privacy Policy Cookie Policy Purchasing & Sales Conditions Legals